Financhill
Back

Halozyme Therapeutics Vs. TransMedics Group Industry Stock Comparison

Buy
72

HALO
Halozyme Therapeutics

Last Price:
58.73
Seasonality Move:
16.49%
Sell
41

TMDX
TransMedics Group

Last Price:
83.01
Seasonality Move:
29.47%
Buy
72
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $58.46. The Score for HALO is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
TransMedics Group (TMDX) is a Sell

Is TransMedics Group a Buy, Sell or Hold?

  • The current TransMedics Group [TMDX] share price is $84.90. The Score for TMDX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • TMDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $58.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight buying pressure.

TMDX Stock Price Chart

What is TransMedics Group's stock price today?

  • The TransMedics Group share price today is $84.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TMDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 64.31 Buy
Chaikin Money Flow: 522918 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.37 - 56.81) Buy
Bollinger Bands (100): (51.47 - 59.79) Buy

TMDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -15.94 Sell
Relative Strength Index (14 RSI): 21.72 Sell
Chaikin Money Flow: 1063697 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (102.1 - 145.12) Sell
Bollinger Bands (100): (126.43 - 164.05) Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.06 Buy
20-day SMA: 52.41 Buy
50-day SMA: 57.09 Buy
200-day SMA: 47.88 Buy
8-day EMA: 53.6 Buy
20-day EMA: 53.47 Buy
50-day EMA: 54.91 Buy
200-day EMA: 50.09 Buy

TMDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 99.14 Sell
20-day SMA: 118.11 Sell
50-day SMA: 139.81 Sell
200-day SMA: 122.14 Sell
8-day EMA: 95.72 Sell
20-day EMA: 113.42 Sell
50-day EMA: 130.94 Sell
200-day EMA: 123.45 Sell

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.66 per share.

TransMedics Group Earnings Growth & TMDX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.53 per share, and an increase next year of $0.63 per share.

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

TransMedics Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):